L. Lard, H. Visser, I. Speyer, I. Vander-horst-bruinsma, A. Zwinderman et al., Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies, The American Journal of Medicine, vol.111, issue.6, pp.446-451, 2001.
DOI : 10.1016/S0002-9343(01)00872-5

E. Lindqvist, K. Eberhardt, K. Bendtzen, D. Heinegard, and T. Saxne, Prognostic laboratory markers of joint damage in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.64, issue.2, pp.196-201, 2005.
DOI : 10.1136/ard.2003.019992

A. Van-der-helm-van-mil, K. Verpoort, F. Breedveld, R. Toes, and T. Huizinga, Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis, Arthritis Research & Therapy, vol.7, issue.5, pp.949-958, 2005.
DOI : 10.1186/ar1767

O. Vittecoq, S. Pouplin, K. Krzanowska, F. Jouen-beades, J. Menard et al., Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients, Rheumatology, vol.42, issue.8, pp.939-946, 2003.
DOI : 10.1093/rheumatology/keg257

K. Forslind, M. Ahlmen, K. Eberhardt, I. Hafstrom, B. Svensson et al., Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP), Annals of the Rheumatic Diseases, vol.63, issue.9
DOI : 10.1136/ard.2003.014233

F. Lago, C. Dieguez, J. Gomez-reino, and O. Gualillo, Adipokines as emerging mediators of immune response and inflammation, Nature Clinical Practice Rheumatology, vol.4, issue.12, pp.716-724, 2007.
DOI : 10.1038/ncprheum0674

M. Scotece, J. Conde, R. Gómez, V. López, J. Pino et al., Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases, Mediators of Inflammation, vol.26, issue.2, p.125458, 2012.
DOI : 10.1007/s00296-010-1651-7

H. Tilg and A. Moschen, Adipocytokines: mediators linking adipose tissue, inflammation and immunity, Nature Reviews Immunology, vol.187, issue.10, pp.772-783, 2006.
DOI : 10.1038/nri1937

C. Heidemann, Q. Sun, R. Van-dam, J. Meigs, C. Zhang et al., Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in Women, Annals of Internal Medicine, vol.149, issue.5, pp.307-316, 2008.
DOI : 10.7326/0003-4819-149-5-200809020-00005

J. Bastard, M. Maachi, C. Lagathu, M. Kim, M. Caron et al., Recent advances in the relationship between obesity, inflammation, and insulin resistance, Eur Cytokine Netw, vol.17, pp.4-12, 2006.

S. Hascoet, M. Elbaz, V. Bongard, F. Bouisset, C. Verdier et al., Adiponectin and Long-Term Mortality in Coronary Artery Disease Participants and Controls, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, issue.1, pp.19-29, 2012.
DOI : 10.1161/ATVBAHA.112.300079

T. Jia, J. Carrero, B. Lindholm, and P. Stenvinkel, The complex role of adiponectin in chronic kidney disease, Biochimie, vol.94, issue.10, pp.2150-2156, 2012.
DOI : 10.1016/j.biochi.2012.02.024

A. Jorsal, L. Tarnow, J. Frystyk, M. Lajer, A. Flyvbjerg et al., Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy, Kidney International, vol.74, issue.5, pp.649-654, 2008.
DOI : 10.1038/ki.2008.201

M. Pham, H. Kolb, T. Mandrup-poulsen, T. Battelino, J. Ludvigsson et al., Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin, Diabetes/Metabolism Research and Reviews, vol.57, issue.2, pp.166-170, 2013.
DOI : 10.1002/dmrr.2378

M. Lemoine, V. Ratziu, M. Kim, M. Maachi, D. Wendum et al., Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease, Liver International, vol.29, issue.9, pp.1431-1438, 2009.
DOI : 10.1111/j.1478-3231.2009.02022.x

E. Neumann, K. Frommer, M. Vasile, and U. Muller-ladner, Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?, Arthritis & Rheumatism, vol.26, issue.5, pp.1159-1169, 2011.
DOI : 10.1002/art.30291

J. Giles, M. Allison, C. Bingham, W. Scott, . Jr et al., Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis, Arthritis & Rheumatism, vol.36, issue.9, pp.1248-1256, 2009.
DOI : 10.1002/art.24789

Y. Rho, J. Solus, T. Sokka, A. Oeser, C. Chung et al., Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis, Arthritis & Rheumatism, vol.47, issue.7, pp.1906-1914, 2009.
DOI : 10.1002/art.24626

I. Klein-wieringa, M. Van-der-linden, R. Knevel, J. Kwekkeboom, E. Van-beelen et al., Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis, Arthritis & Rheumatism, vol.58, issue.Suppl 2, pp.2567-2574, 2011.
DOI : 10.1002/art.30449

J. Giles, D. Van-der-heijde, and J. Bathon, Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.70, issue.9, pp.1562-1568, 2011.
DOI : 10.1136/ard.2011.150813

B. Combe, J. Benessiano, F. Berenbaum, A. Cantagrel, J. Daures et al., The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007.
DOI : 10.1016/j.jbspin.2007.06.001

J. Gottenberg, C. Miceli-richard, B. Ducot, P. Goupille, B. Combe et al., Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort, Arthritis Research & Therapy, vol.11, issue.4, p.114, 2009.
DOI : 10.1186/ar2773
URL : https://hal.archives-ouvertes.fr/inserm-00663622

V. Devauchelle-pensec, J. Berthelot, S. Jousse, I. Samjee, T. Josseaume et al., Performance of hand radiographs in predicting the diagnosis in patients with early arthritis, pp.1511-1515, 2006.

J. Gottenberg, J. Dayer, C. Lukas, B. Ducot, G. Chiocchia et al., Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort, Annals of the Rheumatic Diseases, vol.71, issue.7, pp.1243-1248, 2012.
DOI : 10.1136/annrheumdis-2011-200975
URL : https://hal.archives-ouvertes.fr/hal-00793090

J. Sellam, S. Kotti, S. Fellahi, J. Bastard, M. Meyer et al., Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort, Annals of the Rheumatic Diseases, vol.72, issue.2, pp.312-314, 2013.
DOI : 10.1136/annrheumdis-2012-202119
URL : https://hal.archives-ouvertes.fr/hal-01044536

B. Fautrel, B. Granger, B. Combe, A. Saraux, F. Guillemin et al., Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort, Arthritis Research & Therapy, vol.14, issue.6, p.249, 2012.
DOI : 10.1186/ar4092
URL : https://hal.archives-ouvertes.fr/inserm-00769662

W. Youden, Index for rating diagnostic tests, Cancer, vol.3, issue.1, pp.32-35, 1950.
DOI : 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3

A. Ehling, A. Schaffler, H. Herfarth, I. Tarner, S. Anders et al., The Potential of Adiponectin in Driving Arthritis, The Journal of Immunology, vol.176, issue.7, pp.4468-4478, 2006.
DOI : 10.4049/jimmunol.176.7.4468

K. Frommer, B. Zimmermann, F. Meier, D. Schroder, M. Heil et al., Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis, Arthritis & Rheumatism, vol.5, issue.Suppl 1, pp.2886-2899, 2010.
DOI : 10.1002/art.27616

K. Tong, C. Chen, K. Huang, D. Shieh, H. Cheng et al., Adiponectin increases MMP-3 expression in human chondrocytes through adipor1 signaling pathway, Journal of Cellular Biochemistry, vol.423, issue.5, pp.1431-1440, 2011.
DOI : 10.1002/jcb.23059

R. Lago, R. Gomez, M. Otero, F. Lago, R. Gallego et al., A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes, Osteoarthritis and Cartilage, vol.16, issue.9, pp.1101-1109, 2008.
DOI : 10.1016/j.joca.2007.12.008

X. Chen, J. Lu, J. Bao, J. Guo, J. Shi et al., Adiponectin, pp.83-89, 2013.
DOI : 10.1007/978-3-642-27841-9_103-3

N. Kusunoki, K. Kitahara, F. Kojima, N. Tanaka, K. Kaneko et al., Adiponectin stimulates prostaglandin E2 production in rheumatoid arthritis synovial fibroblasts, Arthritis & Rheumatism, vol.16, issue.6, pp.1641-1649, 2010.
DOI : 10.1002/art.27450

K. Frommer, A. Schaffler, C. Buchler, J. Steinmeyer, M. Rickert et al., Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis? Ann Rheum Dis, pp.1724-1732, 2012.

X. Luo, L. Guo, H. Xie, L. Yuan, X. Wu et al., Adiponectin Stimulates RANKL and Inhibits OPG Expression in Human Osteoblasts Through the MAPK Signaling Pathway, Journal of Bone and Mineral Research, vol.20, issue.10, pp.1648-1656, 2006.
DOI : 10.1359/jbmr.060707

Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda et al., Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity, Biochemical and Biophysical Research Communications, vol.257, issue.1, pp.79-83, 1999.
DOI : 10.1006/bbrc.1999.0255

Y. Okamoto, S. Kihara, T. Funahashi, Y. Matsuzawa, and P. Libby, Adiponectin: a key adipocytokine in metabolic syndrome, Clinical Science, vol.110, issue.3, pp.267-278, 2006.
DOI : 10.1042/CS20050182

S. Wannamethee, G. Lowe, A. Rumley, L. Cherry, P. Whincup et al., Adipokines and Risk of Type 2 Diabetes in Older Men, Diabetes Care, vol.30, issue.5, pp.1200-1205, 2007.
DOI : 10.2337/dc06-2416

A. Van-der-helm-van-mil, S. Van-der-kooij, C. Allaart, R. Toes, and T. Huizinga, A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.67, issue.6, pp.769-774, 2008.
DOI : 10.1136/ard.2007.078832

G. Westhoff, R. Rau, and A. Zink, Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index, Arthritis & Rheumatism, vol.65, issue.11, pp.3575-3582, 2007.
DOI : 10.1002/art.23033

L. Fardet, B. Antuna-puente, C. Vatier, P. Cervera, A. Touati et al., Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy, Clinical Endocrinology, vol.39, issue.1, pp.43-51, 2013.
DOI : 10.1111/j.1365-2265.2012.04348.x

S. Sukumaran, D. Dubois, W. Jusko, and R. Almon, Glucocorticoid Effects on Adiponectin Expression, Vitam Horm, vol.90, pp.163-186, 2012.
DOI : 10.1016/B978-0-12-398313-8.00007-5

. Meyer, Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort, Arthritis Research & Therapy, vol.15, issue.6, pp.10-1186, 2013.
DOI : 10.1111/j.1365-2265.2012.04348.x
URL : https://hal.archives-ouvertes.fr/inserm-00926603